(Q45867379)

English

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice

scientific article published in April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

author name string

Amici A

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Smorlesi A

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Noce G

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Santoni G

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Cappelletti P

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Capparuccia L

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Coppari R

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Lucciarini R

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Petrelli C

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Provinciali M

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

publication date

1 April 2000

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

703-706

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301151

0 references

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

21 January 2018

Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic immunization against neu/erbB2 transgenic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301151

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301151

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10800094

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45867379&oldid=2087667314"